Zacks: Analysts Set $7.50 Price Target for Dynatronics Co. (DYNT)
Shares of Dynatronics Co. (NASDAQ:DYNT) have been given an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Brokers have set a 12-month consensus price target of $7.50 for the company, according to Zacks. Zacks has also given Dynatronics an industry rank of 91 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research upgraded shares of Dynatronics from a “hold” rating to a “buy” rating and set a $3.00 price target on the stock in a report on Tuesday, December 5th.
A hedge fund recently bought a new stake in Dynatronics stock. First Light Asset Management LLC bought a new stake in shares of Dynatronics Co. (NASDAQ:DYNT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 100,000 shares of the medical equipment provider’s stock, valued at approximately $280,000. First Light Asset Management LLC owned about 2.72% of Dynatronics as of its most recent SEC filing. 18.17% of the stock is currently owned by institutional investors.
Shares of Dynatronics (DYNT) traded up $0.07 during trading hours on Thursday, reaching $2.70. 8,840 shares of the company traded hands, compared to its average volume of 13,719. Dynatronics has a one year low of $2.10 and a one year high of $3.75. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.92 and a current ratio of 1.46.
Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 EPS for the quarter, beating the consensus estimate of ($0.08) by $0.08. The company had revenue of $12.80 million for the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. equities analysts forecast that Dynatronics will post -0.09 EPS for the current year.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.